Skip to main content
Skip to main content
REVH logo

Revolution Healthcare Acquisition Corp. (REVH) Stock Analysis

DELISTED 2022

What happened to Revolution Healthcare Acquisition Corp. (REVH) stock?

Revolution Healthcare Acquisition Corp. (REVH) no longer trades on public markets. It was delisted in December 2022. The figures below are historical and are not a current quote.

Vol: 371| 52-wk range: $9.62 – $10.50
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Revolution Healthcare Acquisition Corp. (REVH) trades at $10.04. Revolution Healthcare Acquisition Corp. is a shell company focused on acquiring assets and businesses in the healthcare, life sciences, and technology sectors. Sector: Financial services.

Last analyzed: Mar 18, 2026
Revolution Healthcare Acquisition Corp. is a shell company focused on acquiring assets and businesses in the healthcare, life sciences, and technology sectors. The company was incorporated in 2021 and is based in Cambridge, Massachusetts, seeking opportunities through mergers, share exchanges, or similar business combinations.

Analyst Coverage for REVH: REVH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates REVH against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the REVH film Every key number, told as a short cinematic story — just press play. ~2 min

Revolution Healthcare Acquisition Corp. (REVH) Financial Services Profile

CEOJay S. Markowitz
HeadquartersCambridge, US
IPO Year2021

Revolution Healthcare Acquisition Corp., a special purpose acquisition company (SPAC), targets mergers, acquisitions, and reorganizations within the healthcare, life sciences, and technology sectors. Incorporated in 2021, the company seeks to capitalize on emerging opportunities through strategic business combinations, offering investors exposure to high-growth potential ventures.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for REVH?

As of Mar 18, 2026 — figures reflect the data available on that date.

Revolution Healthcare Acquisition Corp. presents an investment opportunity predicated on its ability to identify and successfully merge with a high-growth company in the healthcare, life sciences, or technology sectors. The potential upside is tied to the target company's future performance and market valuation post-acquisition. Key value drivers include the management team's expertise in deal sourcing and execution, as well as the attractiveness of the target industry. The current P/E ratio is 12.49. A successful acquisition could lead to significant stock appreciation, while failure to find a suitable target poses a risk. Investors should closely monitor the company's progress in identifying and securing a merger candidate.

Based on FMP financials and quantitative analysis

REVH Key Highlights

Revolution Healthcare Acquisition Corp. operates as a special purpose acquisition company (SPAC), focusing on the healthcare, life sciences, and technology sectors.

  • The company's primary objective is to identify and merge with a private company, providing it with a faster route to public listing compared to a traditional IPO.
  • Revolution Healthcare Acquisition Corp. was incorporated in 2021, indicating its relative newness in the SPAC market.
  • The company's headquarters are located in Cambridge, Massachusetts, a hub for biotechnology and technology companies.
  • The current P/E ratio is 12.49.

Who Are REVH's Competitors?

REVH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ACQR Independence Holdings Corp. $10.19 -0.15% $632M 44
AGAC African Gold Acquisition Corporation $10.69 +0.09% $167M 44
BCAC Brookline Capital Acquisition Corp. $22.71 +127.33% $560M 44
AGGI Allied Energy, Inc. $2.25 +32.24% $45.4B 61
GSHN Gushen, Inc. $22.70 +2.71% $9.32B 61
IVAN Ivanhoe Capital Acquisition Corp. $7.68 -2.17% $2.69B 64
APXTW Apex Treasury Corporation $0.35 -5.41% $1.89B 66
APXT Apex Technology Acquisition Corp. $10.12 -0.05% $1.89B 64

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are REVH's Key Strengths?

Experienced management team.

  • Focus on high-growth industries.
  • Access to capital through IPO.
  • Flexibility to pursue a variety of acquisition targets.

What Are REVH's Weaknesses?

Lack of operating history.

  • Dependence on identifying and acquiring a suitable target.
  • Competition from other SPACs.
  • Potential for dilution of shareholder value.

What Could Drive REVH Stock Higher?

Announcement of a definitive merger agreement with a target company.

  • Progress in negotiations with potential acquisition targets.
  • Favorable market conditions for SPACs and IPOs.

What Are the Key Risks for REVH?

Failure to identify and acquire a suitable target company.

  • Changes in regulatory environment for SPACs.
  • Increased competition from other SPACs.
  • Economic downturn that could reduce the availability of capital.
  • Dependence on the management team's ability to execute the company's acquisition strategy.

What Are the Growth Opportunities for REVH?

  • Successful Acquisition: Revolution Healthcare Acquisition Corp.'s primary growth opportunity lies in identifying and acquiring a high-growth company within the healthcare, life sciences, or technology sectors. The successful completion of a merger would transform the company from a shell corporation into an operating entity with significant growth potential. The size of the target market depends on the specific industry and company acquired, but the healthcare and technology sectors are generally characterized by high growth rates and large market opportunities. Timeline: Dependent on market conditions and target availability.
  • Strategic Partnerships: Forming strategic partnerships with established companies in the healthcare, life sciences, or technology sectors could provide Revolution Healthcare Acquisition Corp. with access to deal flow and industry expertise. These partnerships could enhance the company's ability to identify and evaluate potential acquisition targets, increasing the likelihood of a successful merger. The impact of strategic partnerships on growth would depend on the nature and scope of the partnerships formed. Timeline: Ongoing.
  • Expansion into New Sectors: While Revolution Healthcare Acquisition Corp. is currently focused on the healthcare, life sciences, and technology sectors, the company could expand its search to include other industries with high growth potential. This would broaden the pool of potential acquisition targets and increase the company's chances of finding a suitable merger candidate. However, it would also require the company to develop expertise in new industries. Timeline: Medium-term.
  • Geographic Expansion: Revolution Healthcare Acquisition Corp. could expand its search for acquisition targets to include companies located outside of the United States. This would provide access to a larger pool of potential targets and could lead to the identification of undervalued or high-growth businesses. However, it would also require the company to navigate the complexities of international business and regulatory environments. Timeline: Long-term.
  • Leveraging Management Expertise: The management team's expertise in deal sourcing, due diligence, and post-merger integration is a key driver of growth for Revolution Healthcare Acquisition Corp. By leveraging this expertise, the company can increase the likelihood of identifying and successfully merging with a high-growth company. The impact of management expertise on growth is difficult to quantify, but it is a critical factor in the success of any SPAC. Timeline: Ongoing.

What Opportunities Does REVH Have?

  • Growing demand for SPACs as an alternative to traditional IPOs.
  • Increasing investment in the healthcare, life sciences, and technology sectors.
  • Potential to acquire undervalued or high-growth businesses.
  • Opportunity to create value through post-merger integration.

What Are REVH's Competitive Advantages?

  • Management Expertise: The company's management team has experience in deal sourcing, due diligence, and post-merger integration.
  • Industry Focus: The company's focus on the healthcare, life sciences, and technology sectors provides it with a deep understanding of these industries.
  • Access to Capital: The company has access to capital through its IPO, which provides it with the resources to pursue acquisitions.

What Does REVH Do?

Revolution Healthcare Acquisition Corp. was founded in 2021 with the intent to identify and acquire a promising business in the healthcare, life sciences, or technology industries. As a special purpose acquisition company (SPAC), Revolution Healthcare Acquisition Corp. does not have significant operations of its own. Instead, it exists as a publicly traded entity with the sole purpose of merging with or acquiring a private company, thereby taking the target company public without the traditional IPO process. The company's strategy involves leveraging the expertise of its management team to identify undervalued or high-growth potential businesses. Revolution Healthcare Acquisition Corp. is based in Cambridge, Massachusetts, and its activities are centered around sourcing, evaluating, and executing a business combination that will deliver value to its shareholders. The company is currently seeking opportunities within its target sectors, evaluating potential candidates based on their growth prospects, market position, and management capabilities. The successful completion of an acquisition will mark a pivotal moment for Revolution Healthcare Acquisition Corp., transforming it from a shell company into an operating entity with a defined business and strategic direction.

What Products and Services Does REVH Offer?

  • Identifies potential acquisition targets in the healthcare, life sciences, and technology industries.
  • Conducts due diligence on potential acquisition targets.
  • Negotiates merger or acquisition agreements.
  • Raises capital to finance acquisitions.
  • Merges with or acquires a target company.
  • Manages the post-merger integration process.

How Does REVH Make Money?

  • Raises capital through an initial public offering (IPO).
  • Uses the capital raised to acquire a private company.
  • Generates returns for shareholders through the appreciation of the acquired company's stock.

What Industry Does REVH Operate In?

Revolution Healthcare Acquisition Corp. operates within the SPAC market, a segment of the financial services industry characterized by companies formed to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. The SPAC market has experienced significant growth in recent years, driven by the desire of private companies to access public markets more quickly and with less regulatory scrutiny than traditional IPOs. The competitive landscape includes numerous other SPACs, each seeking attractive acquisition targets. The success of Revolution Healthcare Acquisition Corp. depends on its ability to differentiate itself through its industry focus and management expertise.

Who Are REVH's Key Customers?

  • Institutional investors seeking exposure to high-growth companies in the healthcare, life sciences, and technology sectors.
  • Private companies seeking to go public without the traditional IPO process.
  • Shareholders looking for returns through stock appreciation.
AI Confidence: 71% Updated: Mar 18, 2026
P/E 12.5

Key Financial Metrics

Return on assets is 8.4%, showing how much profit it generates from its asset base. REVH trades at a trailing price-to-earnings ratio of 12.49, below the Financial Services sector average of ~18x. A current ratio of 15.11 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 8.0%, the inverse of the P/E and a quick read on earnings relative to price.

Company Profile

Revolution Healthcare Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Cambridge, US. The company is led by CEO Jay S. Markowitz. REVH has traded publicly since 2021.

Net selling

Insider Activity

The most recent 7 insider filings for Revolution Healthcare Acquisition Corp. break down as 7 sales and 0 purchases. On net that is roughly 127K shares disposed (about $56), a signal worth weighing alongside the fundamentals.

REVH Financials

Fundamental Snapshot

P/E (TTM)
12.5
Return on Equity (TTM)
-142.8%
Current Ratio
15.1

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Experienced management team.
  • Focus on high-growth industries.
  • Access to capital through IPO.
  • Flexibility to pursue a variety of acquisition targets.

Bear Case

  • Lack of operating history.
  • Dependence on identifying and acquiring a suitable target.
  • Competition from other SPACs.
  • Potential for dilution of shareholder value.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

REVH Latest News

No recent news available for REVH.

Leadership: Jay S. Markowitz

CEO

Jay S. Markowitz serves as the Chief Executive Officer of Revolution Healthcare Acquisition Corp. His background includes extensive experience in the financial services industry, with a focus on investment banking and mergers and acquisitions. He has held leadership positions at various financial institutions, where he was responsible for advising companies on strategic transactions and capital raising. His expertise spans across multiple sectors, including healthcare, technology, and life sciences. Markowitz holds an MBA from a top-tier business school and a bachelor's degree in finance.

Track Record: Under Jay S. Markowitz's leadership, Revolution Healthcare Acquisition Corp. has been actively pursuing potential acquisition targets in the healthcare, life sciences, and technology sectors. While the company has not yet completed a merger, Markowitz has overseen the evaluation of numerous potential candidates and has been instrumental in developing the company's acquisition strategy. His experience in deal structuring and negotiation is expected to be a key asset in securing a successful merger. The company has not yet completed an acquisition under his leadership.

Revolution Healthcare Acquisition Corp. Financial Services Stock: Key Questions Answered

What happened to Revolution Healthcare Acquisition Corp. (REVH) stock?

Revolution Healthcare Acquisition Corp. (REVH) no longer trades on public markets. It was delisted in December 2022. The figures below are historical and are not a current quote.

Can I still buy REVH shares?

No. REVH stopped trading on public markets in December 2022, so the shares are not available through a broker. Anything you see quoted for REVH elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before REVH stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Revolution Healthcare Acquisition Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Revolution Healthcare Acquisition Corp. do?

Revolution Healthcare Acquisition Corp. is a special purpose acquisition company (SPAC) formed to acquire a company in the healthcare, life sciences, or technology industries. As a SPAC, it has no operating history and exists solely to raise capital through an IPO and then merge with a private company, effectively taking that company public. The success of Revolution Healthcare Acquisition Corp.

What are the main risks for REVH?

The main risks for Revolution Healthcare Acquisition Corp. include the failure to identify and acquire a suitable target company, changes in the regulatory environment for SPACs, increased competition from other SPACs, and an economic downturn that could reduce the availability of capital.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • AI analysis pending for REVH.
  • Information is based on publicly available sources and may be subject to change.
Data Sources

Popular Stocks

More Stocks We Cover